COMP <GO>
NVT vs TMO // FORWARD P/E MULTIPLE
nVent Electric plc Ordinary Shares (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: NVT 7
— TMO 7
▲ FORWARD P/E MULTIPLE LEADER: NVT
LAST: $125.98 (-8.81%) • MKT CAP: $22.36B
forward-pe
26.5x
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
forward-pe
36.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NVT VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NVT | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 37.70% | 41.00% | -3.30 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.90% | 9.30% | +1.60 | NVT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 33.2x | 30.4x | +2.80 | TMO | /valuation <GO> |
| Free Cash Flow Yield | 1.66% | 2.40% | -0.74 | TMO | /fcf-yield <GO> |
| Operating Margin | 15.80% | 17.40% | -1.60 | TMO | /operating-margins <GO> |
| Net Profit Margin | 18.20% | 15.10% | +3.10 | NVT | /net-margins <GO> |
| Revenue Growth (YoY) | 29.50% | 3.90% | +25.60 | NVT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.58% | 0.24% | +0.34 | NVT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.62 | 4.50 | +1.12 | NVT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.70% | +0.50 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.0 | 59.1 | -24.20 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | 0.94 | +0.16 | NVT | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 26.5x | 36.3x | -9.80 | NVT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $22.36B | $262.22B | -$239.86B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NVT REV | TMO REV | NVT GROSS % | TMO GROSS % | NVT FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.89B | $44.56B | 37.7% | 44.0% | $371.9M | $6.29B |
| FY 2024 | $3.01B | $42.88B | 40.2% | 44.0% | $569.1M | $7.27B |
| FY 2023 | $2.67B | $42.86B | 44.0% | 44.0% | $408.0M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NVT // BETA 1.10
TMO // BETA 0.94